Next Article in Journal
Previous Article in Journal
Int. J. Mol. Sci. 2012, 13(11), 14127-14135; doi:10.3390/ijms131114127
Article

Bioavailability and Brain-Targeting of Geniposide in Gardenia-Borneol Co-Compound by Different Administration Routes in Mice

, * ,
,
,
 and
Received: 31 July 2012; in revised form: 9 October 2012 / Accepted: 15 October 2012 / Published: 1 November 2012
(This article belongs to the Section Bioactives and Nutraceuticals)
View Full-Text   |   Download PDF [197 KB, uploaded 19 June 2014]
Abstract: Both geniposide (Ge) and borneol (Bo) are bioactive substances derived from traditional Chinese medicine. Injections containing co-compound of Gardenia-Borneol are widely used for stroke treatment in China, such as “Xingnaojing” multi-component injection. As more and more adverse reactions (especially drug allergy) were reported, it is urgent to find more effective and safer routes of administration for such kinds of medicines. In this paper, bioavailabilities and brain-target effects of geniposide in Gardenia-Borneol co-compound through different administration routes in mice were investigated. Geniposide concentrations in plasma and in brain of mice were determined by reversed-phase high-performance liquid chromatography. The pharmacokinetics parameters of intranasal (i.n.) and intragastric (i.g.) administration were compared with intravenous (i.v.) administration. The bioavailabilities of Ge were 85.38% and 28.76% for i.n. and i.g. while Tmax were 1 min and 30 min. Cmax were 21.881 ± 5.398, 1.914 ± 0.327 and 42.410 ± 6.268 μg/mL for i.n., i.g. and i.v., respectively. The AUC of Ge in brain were 32413.6 ± 4573.9, 6440.1 ± 863.7 and 37270.5 ± 4160.6 ng/g·min for i.n., i.g. and i.v., respectively. The drug target indexes (DTI) were 1.02 and 0.60 for i.n. and i.g. The results demonstrated that geniposide could be absorbed promptly and thoroughly by i.n. administration in mice and basically transported into the brain though blood vessel passways.
Keywords: geniposide; borneol; intranasal; intragastric; intravenous; pharmacokinetics; brain-target geniposide; borneol; intranasal; intragastric; intravenous; pharmacokinetics; brain-target
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Lu, Y.; Du, S.; Bai, J.; Li, P.; Wen, R.; Zhao, X. Bioavailability and Brain-Targeting of Geniposide in Gardenia-Borneol Co-Compound by Different Administration Routes in Mice. Int. J. Mol. Sci. 2012, 13, 14127-14135.

AMA Style

Lu Y, Du S, Bai J, Li P, Wen R, Zhao X. Bioavailability and Brain-Targeting of Geniposide in Gardenia-Borneol Co-Compound by Different Administration Routes in Mice. International Journal of Molecular Sciences. 2012; 13(11):14127-14135.

Chicago/Turabian Style

Lu, Yang; Du, Shouying; Bai, Jie; Li, Pengyue; Wen, Ran; Zhao, Xuejiao. 2012. "Bioavailability and Brain-Targeting of Geniposide in Gardenia-Borneol Co-Compound by Different Administration Routes in Mice." Int. J. Mol. Sci. 13, no. 11: 14127-14135.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert